Glucose sensing O-GlcNAcylation pathway regulates the nuclear bile acid receptor farnesoid X receptor (FXR)

Hepatology

Volumn 59, Issue 5, 2014, Pages 2022-2033

  Berrabah, Wahiba ^a,b,c,d   Aumercier, Pierrette ^a,b,c,d   Gheeraert, Céline ^a,b,c,d   Dehondt, Hélène ^a,b,c,d   Bouchaert, Emmanuel ^a,b,c,d   Alexandre, Jérémy ^a,b,c,d   Ploton, Maheul ^a,b,c,d   Mazuy, Claire ^a,b,c,d   Caron, Sandrine ^a,b,c,d   Tailleux, Anne ^a,b,c,d   Eeckhoute, Jérôme ^a,b,c,d   Lefebvre, Tony ^e   Staels, Bart ^a,b,c,d   Lefebvre, Philippe ^a,b,c,d  

^a France   (France)

^b INSERM UMR1011 ^*  (France)

^c UNIV LILLE   (France)

^d INSTITUT PASTEUR DE LILLE   (France)

^e UNIVERSITÉ DES SCIENCES ET TECHNOLOGIES DE LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLATION; ANIMALS; BILE ACIDS AND SALTS; GENE EXPRESSION REGULATION; GLUCOSE; HEP G2 CELLS; HEPATOCYTES; HEXOSAMINES; HUMANS; MALE; MICE; MICE, INBRED C57BL; N-ACETYLGLUCOSAMINYLTRANSFERASES; PENTOSE PHOSPHATE PATHWAY; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SIGNAL TRANSDUCTION;

EID: 84899475842     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.26710     Document Type: Article

References (34)

1. Hart GW, Akimoto Y. The O-GlcNAc Modification. 2009. In: Varki A, Cummings RD, Esko JD, et al., editors. Essentials of glycobiology, 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 2009: Chapter 18.
2. Hart GW, Slawson C, Ramirez-Correa G, Lagerlof O. Cross talk between O-GlcNAcylation and phosphorylation: roles in signaling, transcription, and chronic disease. Annu Rev Biochem 2011;80:825-858.
3. Ozcan S, Andrali SS, Cantrell JE. Modulation of transcription factor function by O-GlcNAc modification. Biochim Biophys Acta 2010;1799:353-364.
4. Hanover JA, Krause MW, Love DC. Bittersweet memories: linking metabolism to epigenetics through O-GlcNAcylation. Nat Rev Mol Cell Biol 2012;13:312-321.
5. Toleman C, Paterson AJ, Whisenhunt TR, Kudlow JE. Characterization of the histone acetyltransferase (HAT) domain of a bifunctional protein with activable O-GlcNAcase and HAT activities. J Biol Chem 2004;279:53665-53673.
6. Lefebvre P, Cariou B, Lien F, Kuipers F, Staels B. Role of bile acids and bile acid receptors in metabolic regulation. Physiol Rev 2009;89:147-191.
7. Duran-Sandoval D, Cariou B, Percevault F, Hennuyer N, Grefhorst A, van Dijk TH, et al. The Farnesoid X receptor modulates hepatic carbohydrate metabolism during the fasting-refeeding transition. J Biol Chem 2005;280:29971-29979.
8. Caron S, Huaman C, Dehondt H, Lien F, Briand O, Lefebvre P, et al. Farnesoid X receptor inhibits glucose-induced LPK gene expression by interfering with carbohydrate response element binding protein (ChREBP) activity. Mol Cell Biol 2013;33:2202-2211.
9. Duran-Sandoval D, Mautino G, Martin G, Percevault F, Barbier O, Fruchart JC, et al. Glucose regulates the expression of the farnesoid X receptor in liver. Diabetes 2004;53:890-898.
10. Matysik S, Martin J, Bala M, Scherer M, Schaffler A, Schmitz G. Bile acid signaling after an oral glucose tolerance test. Chem Phys Lipids 2011;164:525-529.
11. Sinal CJ, Tohkin M, Miyata M, Ward JM, Lambert G, Gonzalez FJ. Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis. Cell 2000;102:731-744.
12. Prawitt J, Abdelkarim M, Stroeve JH, Popescu I, Duez H, Velagapudi VR, et al. FXR deficiency improves glucose homeostasis in mouse models of obesity. Diabetes 2011;60:1861-1871.
13. Ananthanarayanan M, Balasubramanian N, Makishima M, Mangelsdorf DJ, Suchy FJ. Human bile salt export pump promoter is transactivated by the farnesoid X receptor/bile acid receptor. J Biol Chem 2001;276:28857-28865.
14. Zhao A, Lew JL, Huang L, Yu J, Zhang T, et al. Human kininogen gene is transactivated by the farnesoid X receptor. J Biol Chem 2003;278:28765-28770.
15. Lee J, Seok S, Yu P, Kim K, Smith Z, Rivas-Astroza M, et al. Genomic analysis of hepatic FXR binding sites reveals altered binding in obesity and direct gene repression by FXR in mice. Hepatology 2012;56:108-117.
16. Flatt B, Martin R, Wang TL, Mahaney P, Murphy B, Gu XH, et al. Discovery of XL335 (WAY-362450), a highly potent, selective, and orally active agonist of the farnesoid X receptor (FXR). J Med Chem 2009;52:904-907.
17. Samanez CH, Caron S, Briand O, Dehondt H, Duplan I, Kuipers F, et al. The human hepatocyte cell lines IHH and HepaRG: models to study glucose, lipid and lipoprotein metabolism. Arch Physiol Biochem 2012;118:102-111.
18. Fischle W, Dequiedt F, Hendzel MJ, Guenther MG, Lazar MA, Voelter W, et al. Enzymatic activity associated with class II HDACs is dependent on a multiprotein complex containing HDAC3 and SMRT/N-CoR. Mol Cell 2002;9:45-57.
19. Anthonisen EH, Berven L, Holm S, Nygard M, Nebb HI, Gronning-Wang LM. Nuclear receptor LXR is O-GlcNAc-modified in response to glucose. J Biol Chem 2010;285:1607-1615.
20. Ji S, Park SY, Roth J, Kim HS, Cho JW. O-GlcNAc modification of PPARγ reduces its transcriptional activity. Biochem Biophys Res Commun 2012;417:1158-1163.
21. Li MD, Ruan HB, Singh JP, Zhao L, Zhao T, Azarhoush S, et al. O-GlcNAc transferase is involved in glucocorticoid receptor-mediated transrepression. J Biol Chem 2012;287:12904-12912.
22. Zhang S, Danielsen M. Evidence denies the presence of O-GlcNAcylation on mouse glucocorticoid receptor and its potential involvement in receptor transcriptional activity. J Recept Signal Transduct Res 2006;26:129-145.
23. Kemper JK, Xiao Z, Ponugoti B, Miao J, Fang S, Kanamaluru D, et al. FXR acetylation is normally dynamically regulated by p300 and SIRT1 but constitutively elevated in metabolic disease states. Cell Metab 2009;10:392-404.
24. Guinez C, Mir AM, Dehennaut V, Cacan R, Harduin-Lepers A, Michalski JC, et al. Protein ubiquitination is modulated by O-GlcNAc glycosylation. FASEB J 2008;22:2901-2911.
25. Zhang F, Su K, Yang X, Bowe DB, Paterson AJ, Kudlow JE. O-GlcNAc modification is an endogenous inhibitor of the proteasome. Cell 2003;115:715-725.
26. Bowe DB, Sadlonova A, Toleman CA, Novak Z, Hu Y, Huang P, et al. O-GlcNAc integrates the proteasome and transcriptome to regulate nuclear hormone receptors. Mol Cell Biol 2006;26:8539-8550.
27. Ananthanarayanan M, Li S, Balasubramaniyan N, Suchy FJ, Walsh MJ. Ligand-dependent activation of FXR directs arginine methylation of histone H3 by CARM1. J Biol Chem 2004;279:54348-54357.
28. Cheung WD, Sakabe K, Housley MP, Dias WB, Hart GW. O-linked beta-N-acetylglucosaminyltransferase substrate specificity is regulated by myosin phosphatase targeting and other interacting proteins. J Biol Chem 2008;283:33935-33941.
29. Chen Q, Chen Y, Bian C, Fujiki R, Yu X. TET2 promotes histone O-GlcNAcylation during gene transcription. Nature 2012;493:561-564.
30. Ruan HB, Han X, Li MD, Singh JP, Qian K, Azarhoush S, et al. O-GlcNAc transferase/host cell factor C1 complex regulates gluconeogenesis by modulating PGC-1α stability. Cell Metab 2012;16:226-237.
31. Kanaya E, Shiraki T, Jingami H. The nuclear bile acid receptor FXR is activated by PGC-1alpha in a ligand-dependent manner. Biochem J 2004;382(Pt 3):913-921.
32. Zhang Y, Castellani LW, Sinal CJ, Gonzalez FJ, Edwards PA. Peroxisome proliferator-activated receptor γ coactivator 1α (PGC-1α) regulates triglyceride metabolism by activation of the nuclear receptor FXR. Genes Dev 2004;18:157-169.
33. Ranuncolo SM, Ghosh S, Hanover JA, Hart GW, Lewis BA. Evidence of the involvement of O-GlcNAc-modified human RNA polymerase II CTD in transcription in vitro and in vivo. J Biol Chem 2012;287:23549-23561.
34. Slawson C, Copeland RJ, Hart GW. O-GlcNAc signaling: a metabolic link between diabetes and cancer? Trends Biochem Sci 2010;35:547-555.